ICD-10-CM Billable Code

C51.0

Malignant neoplasm of labium majus

Clinical Classification Guidelines

Inclusion Terms

  • Malignant neoplasm of Bartholin's [greater vestibular] gland

Medical Intelligence & Overview

Malignant neoplasm of the labium majus, classified under ICD-10 code C51.0, refers to a type of skin cancer developing on the outer fold of the female vulva. This condition involves the growth of abnormal, cancerous cells that originate from the tissues of the labium majus, which are the outer lips of the vulva. Although it often encompasses tumors arising in areas like Bartholin's glands, it primarily describes malignant transformations in the labial tissue. Recognizing this condition early is essential for effective management and treatment options, aimed at removing the cancerous tissue and preventing its spread.

Causes & Symptoms

Clinical Causes: Persistent human papillomavirus (HPV) infection, especially high-risk types Chronic irritation or inflammation of vulvar tissues History of vulvar intraepithelial neoplasia or other precancerous conditions Smoking and other tobacco use habits Weakened immune system, such as in autoimmune diseases or immunosuppressive therapy Age-related risks, more common in women over 50 Certain genetic predispositions

Key Symptoms: A persistent, non-healing sore or ulcer on the vulva A new growth or lump that does not resolve over time Itching or irritation in the affected area Discoloration or thickening of the skin on the vulva Pain or discomfort during urination or sexual activity Bleeding or unusual discharge from the vulvar area Swelling or enlarged lymph nodes in the groin region

Diagnostic & Treatment

Diagnosis Path: Diagnosing malignant neoplasm of the labium majus typically involves a combination of clinical evaluation and laboratory tests. A healthcare provider will perform a physical pelvic examination to inspect for visible abnormalities or suspicious lesions. A biopsy, where a sample of tissue is surgically removed and examined microscopically, is essential to confirm malignancy. Further imaging studies such as ultrasound, MRI, or CT scans may be used to assess the extent of local invasion or potential spread to lymph nodes and other tissues. Additional blood tests are not specific but may assist in overall health assessment.

Treatment Protocols: Treating malignant neoplasm of the labium majus often requires a multidisciplinary approach, tailored to the stage and severity of the cancer. Common management options include: - Surgical excision to remove the tumor and adjacent tissue, which may range from local wide excision to more extensive vulvectomies - Radiation therapy aimed at destroying cancer cells, especially when surgical removal is limited or as an adjunct to surgery - Chemotherapy may be considered in cases where the cancer has spread beyond the primary site - Targeted therapies or immunotherapies might be options, depending on specific tumor characteristics and advancements in treatment - Follow-up care regularly to monitor for recurrence or metastasis Early detection and intervention significantly improve outcomes, emphasizing the importance of medical evaluation for any suspicious vulvar lesions.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C51.0 a billable ICD-10 code?
Yes, C51.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C51.0?
Clinical documentation must specify the nature of Malignant neoplasm of labium majus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

majus neoplasm labium malignant